Representation of Jerusalem Economy Ltd. (JEL), the parent company of Industrial Buildings Corporation (IBC) – both publicly traded companies in Israel – in a precedential statutory merger pursuant to which JEL merged with and into IBC, with IBC being the surviving company in the merger, and shareholders of JEL receiving shares of IBC; such shares […]
FBC represented Holmes Place International Ltd. (“Holmes Place Israel”) with respect to receipt of a NIS 45M credit facility from The Phoenix Insurance Company Ltd. (and related entities), and both credit lines and a long term loan in the aggregate amount of NIS 45M from Bank Mizrahi Tefahot Ltd., together with a simultaneous equity investment […]
FBC advises Perrigo, a NYSE and TASE-traded company, in the Israeli aspects relating to the $8.6B acquisition of Elan Corporation and the reincorporation of Perrigo in Ireland.
FBC advises Monsanto, in an investment in Evogene, a publicly traded Israeli company that develops genetic engineering technology, in its acquisition of Rosetta Green, a public Israeli company, and the Beelogics group of companies.
General Search
Practice Area
Attorney
Date
Publication Type